MRI-TRUS Fusion

MRI Fusion Biopsies

What are MRI Fusion Biopsies?

MRI fusion biopsies is technology that combines magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS) to improve the accuracy of prostate biopsies. It creates a 3D model of the prostate from MRI data and then overlays it onto the real-time ultrasound image, allowing doctors to precisely target suspicious areas for sampling. This method enhances cancer detection, particularly for lesions that may be missed by standard biopsy techniques.

Benefits of MRI Fusion Biopsy:

Improved Cancer Detection:
Studies show that MRI-TRUS fusion biopsy can detect more significant prostate cancers compared to standard biopsy techniques, especially in areas like the anterior prostate and apex.

Reduced Unnecessary Biopsies:
By targeting specific lesions, it may reduce the number of biopsies needed and the detection of insignificant cancers.

Precise Targeting:
The fused images allow for accurate targeting of lesions, even those that are difficult to visualize with ultrasound alone.

Monitoring:
The technology allows for follow-up biopsies to monitor changes in the targeted area over time.